Platelet-specific JAM-A deficiency in apoe(-/-) mice fed a high-fat diet caused increased aortic plaque formation, particularly in early stages of the disease.
Does platelet-specific JAM-A deficiency accelerate aortic plaque formation in hyperlipidemic apoe(-/-) mice?
Platelet hyperreactivity induced by JAM-A deficiency accelerates early atherosclerosis and increases inflammatory cell recruitment in hyperlipidemic mice.
RATIONALE: Besides their essential role in hemostasis, platelets also have functions in inflammation. In platelets, junctional adhesion molecule (JAM)-A was previously identified as an inhibitor of integrin αIIbβ3-mediated outside-in signaling and its genetic knockdown resulted in hyperreactivity. OBJECTIVE: This gain-of-function was specifically exploited to investigate the role of platelet hyperreactivity in plaque development. METHODS AND RESULTS: JAM-A-deficient platelets showed increased aggregation and cellular and sarcoma tyrosine-protein kinase activation. On αIIbβ3 ligation, JAM-A was shown to be dephosphorylated, which could be prevented by protein tyrosine phosphatase nonreceptor type 1 inhibition. Mice with or without platelet-specific (tr)JAM-A-deficiency in an apolipoprotein e (apoe(-/-)) background were fed a high-fat diet. After ≤12 weeks of diet, trJAM-A(-/-)apoe-/- mice showed increased aortic plaque formation when compared with trJAM-A(+/+) apoe(-/-) controls, and these differences were most evident at early time points. At 2 weeks, the plaques of the trJAM-A(-/-) apoe(-/-) animals revealed increased macrophage, T cell, and smooth muscle cell content. Interestingly, plasma levels of chemokines CC chemokine ligand 5 and CXC-chemokine ligand 4 were increased in the trJAM-A(-/-) apoe(-/-)mice, and JAM-A-deficient platelets showed increased binding to monocytes and neutrophils. Whole-blood perfusion experiments and intravital microscopy revealed increased recruitment of platelets and monocytes to the inflamed endothelium in blood of trJAM-A(-/-) apoe(-/-)mice. Notably, these proinflammatory effects of JAM-A-deficient platelets could be abolished by the inhibition of αIIbβ3 signaling in vitro. CONCLUSIONS: Deletion of JAM-A causes a gain-of-function in platelets, with lower activation thresholds and increased inflammatory activities. This leads to an increase of plaque formation, particularly in early stages of the disease.
Karshovska et al. (Thu,) conducted a other in Atherosclerosis. Platelet-specific JAM-A deficiency vs. trJAM-A(+/+) apoe(-/-) controls was evaluated on Aortic plaque formation. Platelet-specific JAM-A deficiency in apoe(-/-) mice fed a high-fat diet caused increased aortic plaque formation, particularly in early stages of the disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: